XGN
Income statement / Annual
Last year (2023), Exagen Inc.'s total revenue was $52.55 M,
an increase of 15.33% from the previous year.
In 2023, Exagen Inc.'s net income was -$23.69 M.
See Exagen Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
| Operating Revenue |
$52.55 M
|
$45.56 M
|
$48.30 M
|
$41.98 M
|
$40.39 M
|
$32.44 M
|
$26.81 M
|
$17.95 M
|
$11.66 M
|
$3.06 M
|
| Cost of Revenue |
$23.09 M |
$24.21 M |
$20.59 M |
$16.56 M |
$18.81 M |
$15.38 M |
$14.14 M |
$9.53 M |
$6.89 M |
$2.83 M |
| Gross Profit |
$29.46 M |
$21.35 M |
$27.71 M |
$25.42 M |
$21.58 M |
$17.06 M |
$12.67 M |
$8.41 M |
$4.78 M |
$225,000.00 |
| Gross Profit Ratio |
0.56 |
0.47 |
0.57 |
0.61 |
0.53 |
0.53 |
0.47 |
0.47 |
0.41 |
0.07 |
| Research and Development
Expenses |
$4.87 M
|
$9.88 M
|
$7.24 M
|
$3.57 M
|
$2.18 M
|
$2.13 M
|
$1.55 M
|
$1.37 M
|
$1.29 M
|
$897,000.00
|
| General & Administrative
Expenses |
$45.93 M
|
$49.02 M
|
$42.84 M
|
$35.73 M
|
$27.10 M
|
$18.28 M
|
$17.52 M
|
$15.91 M
|
$13.97 M
|
$6.56 M
|
| Selling & Marketing
Expenses |
$1.50 M
|
$3.00 M
|
$1.70 M
|
$1.30 M
|
$1.60 M
|
$1.40 M
|
$1.30 M
|
$1.50 M
|
$1.10 M
|
$429,000.00
|
| Selling, General &
Administrative Expenses |
$47.43 M
|
$52.02 M
|
$44.54 M
|
$37.03 M
|
$28.70 M
|
$19.68 M
|
$18.82 M
|
$17.41 M
|
$15.07 M
|
$6.99 M
|
| Other Expenses |
$0.00 |
$5.51 M |
$16,000.00 |
$984,000.00 |
$510,000.00 |
$141,000.00 |
$186,000.00 |
$1.22 M |
-$497,000.00 |
-$83,000.00 |
| Operating Expenses |
$52.29 M |
$61.89 M |
$51.78 M |
$40.60 M |
$30.88 M |
$21.94 M |
$20.56 M |
$19.07 M |
$16.57 M |
$8.10 M |
| Cost And Expenses |
$75.39 M |
$86.11 M |
$72.37 M |
$57.16 M |
$49.69 M |
$37.32 M |
$34.69 M |
$28.60 M |
$23.46 M |
$10.93 M |
| Interest Income |
$1.52 M |
$830,000.00 |
$16,000.00 |
$2.28 M |
$2.98 M |
$112,000.00 |
$45,000.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$2.34 M |
$2.45 M |
$2.63 M |
$2.57 M |
$3.49 M |
$2.87 M |
$2.95 M |
$4.50 M |
$2.94 M |
$941,000.00 |
| Depreciation &
Amortization |
$2.17 M
|
$2.11 M
|
$948,000.00
|
$546,000.00
|
$591,000.00
|
$731,000.00
|
$670,000.00
|
$879,000.00
|
$558,000.00
|
$455,000.00
|
| EBITDA |
-$19.15 M
|
-$43.11 M
|
-$23.10 M
|
-$13.66 M
|
-$7.93 M
|
-$4.36 M
|
-$22.56 M
|
-$13.55 M
|
-$11.50 M
|
-$12.06 M
|
| EBITDA Ratio |
-0.36 |
-0.87 |
-0.5 |
-0.34 |
-0.22 |
-0.12 |
-0.27 |
-0.48 |
-1.01 |
-2.46 |
| Operating Income Ratio
|
-0.43
|
-0.89
|
-0.5
|
-0.36
|
-0.23
|
-0.15
|
-0.29
|
-0.58
|
-0.99
|
-2.99
|
| Total Other
Income/Expenses Net |
-$819,000.00
|
-$1.62 M
|
-$2.61 M
|
-$1.58 M
|
-$2.71 M
|
-$3.07 M
|
-$18.34 M
|
-$8.54 M
|
-$3.44 M
|
-$4.31 M
|
| Income Before Tax |
-$23.66 M |
-$47.67 M |
-$26.68 M |
-$16.77 M |
-$12.01 M |
-$7.95 M |
-$26.18 M |
-$18.93 M |
-$14.99 M |
-$13.45 M |
| Income Before Tax Ratio
|
-0.45
|
-1.05
|
-0.55
|
-0.4
|
-0.3
|
-0.25
|
-0.98
|
-1.05
|
-1.29
|
-4.4
|
| Income Tax Expense |
$33,000.00 |
-$282,000.00 |
$175,000.00 |
-$79,000.00 |
$25,000.00 |
$58,000.00 |
-$549,000.00 |
$253,000.00 |
-$13,000.00 |
$42,000.00 |
| Net Income |
-$23.69 M |
-$47.39 M |
-$26.85 M |
-$16.69 M |
-$12.04 M |
-$8.01 M |
-$25.63 M |
-$19.18 M |
-$14.98 M |
-$13.50 M |
| Net Income Ratio |
-0.45 |
-1.04 |
-0.56 |
-0.4 |
-0.3 |
-0.25 |
-0.96 |
-1.07 |
-1.28 |
-4.42 |
| EPS |
-1.34 |
-2.77 |
-1.68 |
-1.32 |
-0.96 |
-127.16 |
-406.81 |
-305.48 |
-265.79 |
-251.43 |
| EPS Diluted |
-1.34 |
-2.77 |
-1.68 |
-1.32 |
-0.96 |
-127.16 |
-406.81 |
-305.48 |
-265.79 |
-251.43 |
| Weighted Average Shares
Out |
$17.68 M
|
$17.08 M
|
$15.97 M
|
$12.65 M
|
$12.56 M
|
$63,005.00
|
$63,005.00
|
$62,797.00
|
$56,364.00
|
$53,676.00
|
| Weighted Average Shares
Out Diluted |
$17.68 M
|
$17.08 M
|
$15.97 M
|
$12.65 M
|
$12.56 M
|
$63,005.00
|
$63,005.00
|
$62,797.00
|
$56,364.00
|
$53,676.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
